Reversible and irreversible injury in the reperfused myocardium: differentiation with contrast material-enhanced MR imaging

Radiology
M SaeedC B Higgins

Abstract

Thrombolytic agents are being used with increasing frequency to produce reperfusion of acute myocardial infarction in humans. This study was designed to assess the potential of a magnetic resonance (MR) contrast agent, the manganese chelate of N,N'-bis(pyridoxal-5-phosphate) ethylenediamine-N,N'-diacetic acid (DPDP), in differentiating between reversible and irreversible myocardial injury during reperfusion. Ischemia was produced in rats by occlusion of the left coronary artery for either 15 minutes (n = 10) or 2 hours (n = 10), followed in both cases by 30 minutes of reperfusion. Signal intensity (SI) was measured before and after (every 15 minutes for 1 hour) the administration of Mn-DPDP. Prior to intravenous injection of the contrast agent, no significant difference in SI was observed between normal and reversibly or irreversibly injured myocardium. Mn-DPDP produced greater enhancement of SI of the irreversibly injured region compared with normal myocardium. There was no differential enhancement of the reversibly injured region compared with normal myocardium. Thus, Mn-DPDP is useful in discriminating reversible from irreversible injury in reperfused myocardium.

Citations

Oct 15, 2013·Clinical Research in Cardiology : Official Journal of the German Cardiac Society·M F Braggion-SantosH Steen
Oct 21, 2011·Radiology·Karen G Ordovas, Charles B Higgins
May 1, 1994·Journal of Magnetic Resonance Imaging : JMRI·M SaeedC B Higgins
Dec 1, 1991·Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine·C B HigginsM Wendland
Jan 1, 1994·Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine·M SaeedC B Higgins
Jan 1, 1996·Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine·I MottetJ Pringot
Mar 1, 1997·Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine·M F WendlandC B Higgins
May 24, 2011·Progress in Nuclear Magnetic Resonance Spectroscopy·Małgorzata Norek, Joop A Peters
Dec 1, 2007·Contrast Media & Molecular Imaging·Daniel C MedinaSteven E Anderson
Aug 23, 2005·European Journal of Heart Failure·Oliver ZimmermannJan Torzewski
Jul 1, 1996·American Heart Journal·J C SteffansC B Higgins
Apr 10, 2009·JACC. Cardiovascular Imaging·Charles B Higgins
Apr 6, 2004·Korean Journal of Radiology : Official Journal of the Korean Radiological Society·Jong Min ParkSang-Hee Choi
Mar 17, 1999·Journal of Magnetic Resonance Imaging : JMRI·H C RobertsR C Brasch
Nov 5, 1999·Journal of Magnetic Resonance Imaging : JMRI·T H Lim, S I Choi
Jan 1, 1993·Journal of Magnetic Resonance Imaging : JMRI·C B HigginsN Kanth

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.